Literature DB >> 9361013

The noncatalytic C-terminal segment of the T cell protein tyrosine phosphatase regulates activity via an intramolecular mechanism.

L Hao1, T Tiganis, N K Tonks, H Charbonneau.   

Abstract

Human T cell protein tyrosine phosphatase (TCPTP) is a nontransmembrane enzyme, the first of the protein tyrosine phosphatase family to be cloned. Alternative mRNA splicing results in variation in the sequence at the extreme C terminus of TCPTP and generates a 45-kDa form (TC45) that is targeted to the nucleus and a 48-kDa variant (TC48) associated with membranes of the endoplasmic reticulum. In this report, we assessed the role of the C-terminal, noncatalytic segment of TCPTP in regulating activity, concentrating primarily on the TC45 variant. We have demonstrated that limited tryptic proteolysis of TC45 releases first a 42-kDa fragment, then a 33-kDa catalytic domain. Using reduced carboxyamidomethylated and maleylated lysozyme as substrate (RCML), the catalytic domain displays 20-100-fold more activity than the full-length enzyme. Analysis of the time course of limited trypsinolysis revealed that proteolytic activation occurred following cleavage of a protease-sensitive region (residues 353-387) located at the C terminus of TC45. The activity of truncation mutants illustrated that removal of 20 C-terminal residues was sufficient to activate the enzyme fully. The 33-kDa catalytic domain, but not the full-length enzyme, was inhibited in a concentration-dependent manner by addition of the noncatalytic C-terminal segment of TC45. A monoclonal antibody to TCPTP, CF4, which recognizes an epitope located between residues 350 and 363, was capable of fully activating TC45. These data indicate that the noncatalytic segment of TC45 contains an autoregulatory site that modulates activity via a reversible intramolecular interaction with the catalytic domain. These studies suggest that the C-terminal noncatalytic segment of TC45, and possibly TC48, may not only direct the enzyme to different subcellular locations but may also modulate activity in response to the binding of regulatory proteins and/or posttranslational modification.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361013     DOI: 10.1074/jbc.272.46.29322

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

Authors:  Thomas Meyer; Andreas Marg; Petra Lemke; Burkhard Wiesner; Uwe Vinkemeier
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

Review 2.  Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22.

Authors:  Karen Cerosaletti; Jane H Buckner
Journal:  Rev Diabet Stud       Date:  2012-12-28

3.  Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function.

Authors:  Harrison M Penrose; Ronald R Marchelletta; Moorthy Krishnan; Declan F McCole
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

Review 4.  Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Authors:  Nicholas K Tonks
Journal:  FEBS J       Date:  2013-01-17       Impact factor: 5.542

5.  T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6.

Authors:  Xiaoqing Lu; Jun Chen; R Tedjo Sasmono; Eric D Hsi; Kristopher A Sarosiek; Tony Tiganis; Izidore S Lossos
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

6.  Protein tyrosine phosphatase hPTPN20a is targeted to sites of actin polymerization.

Authors:  Michelle T Fodero-Tavoletti; Matthew P Hardy; Brent Cornell; Frosa Katsis; Christine M Sadek; Christina A Mitchell; Bruce E Kemp; Tony Tiganis
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

7.  An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering.

Authors:  Daniel A Keedy; Zachary B Hill; Justin T Biel; Emily Kang; T Justin Rettenmaier; José Brandão-Neto; Nicholas M Pearce; Frank von Delft; James A Wells; James S Fraser
Journal:  Elife       Date:  2018-06-07       Impact factor: 8.140

8.  Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.

Authors:  Zhimin Chen; Xiaoxiao Sun; Shensi Shen; Haohao Zhang; Xiuquan Ma; Jingli Liu; Shan Kuang; Qiang Yu
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

9.  Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain.

Authors:  Yingge Liu; Stephanie M Stanford; Sonali P Jog; Edoardo Fiorillo; Valeria Orrú; Lucio Comai; Nunzio Bottini
Journal:  Biochemistry       Date:  2009-08-11       Impact factor: 3.162

10.  Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase.

Authors:  Elina Mattila; Heidi Marttila; Niko Sahlberg; Pekka Kohonen; Siri Tähtinen; Pasi Halonen; Merja Perälä; Johanna Ivaska
Journal:  BMC Cancer       Date:  2010-01-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.